Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 (CSGALNACT1) Peptide
-
- Target See all CSGALNACT1 products
- CSGALNACT1 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 (CSGALNACT1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- DELTPEQYKM CMQSKAMNEA SHGQLGMLVF RHEIEAHLRK QKQKTSSKKT
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ChGn antibody,
Alternative Names: CHGN control peptide, CHGN antibody Blocking Peptide, Anti-CHGN Blocking Peptide, FLJ11264 Blocking Peptide, beta4GalNAcT Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- CSGALNACT1 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 (CSGALNACT1))
- Background
- ChGn transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). This protein is required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains. It play an important role in chondroitin chain biosynthesis in cartilage.
- Molecular Weight
- 61 kDa
-